Works matching IS 10837159 AND DT 2014 AND VI 19 AND IP 11
Results: 20
Clinical Trial Results. A Phase I/II Study of XELIRI Plus Bevacizumab as Second-Line Chemotherapy for Japanese PatientsWithMetastatic Colorectal Cancer (BIX Study)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
In Reply.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Symptom Management and Supportive Care. A Prospective Study of Shortened Vitamin Supplementation Prior to Cisplatin-Pemetrexed Therapy for Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1193, doi. 10.1634/theoncologist.2014-0221
- By:
- Publication type:
- Article
Drug Development for Hepatocellular Carcinoma: Knowing the Past Helps to Understand the Future.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1114, doi. 10.1634/theoncologist.2014-0304
- By:
- Publication type:
- Article
Updated Product Label Allows Home Administration of Omacetaxine Mepesuccinate.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Symptom Management and Supportive Care. The Opioid Rotation Ratio of Hydrocodone to Strong Opioids in Cancer Patients.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1185, doi. 10.1634/theoncologist.2014-0130
- By:
- Publication type:
- Article
Efficacy and Safety of the FOLFOX4 Regimen Versus Doxorubicin in Chinese Patients With Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the EACH Study.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1168, doi. 10.1634/theoncologist.2014-0190
- By:
- Publication type:
- Article
Clinical Trial Results. S-1 as Monotherapy or in Combination With Leucovorin as Second-Line Treatment in Gemcitabine-Refractory Advanced Pancreatic Cancer: A Randomized, Open-Label, Multicenter, Phase II Study.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1132, doi. 10.1634/theoncologist.2014-0223
- By:
- Publication type:
- Article
Symptom Management and Supportive Care. Sleep-Related Breathing Disorders in Patients With Tumors in the Head and Neck Region.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1199, doi. 10.1634/theoncologist.2014-0176
- By:
- Publication type:
- Article
Gene Status in HER2 Equivocal Breast Carcinomas: Impact of Distinct Recommendations and Contribution of a Polymerase Chain Reaction-BasedMethod.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1117, doi. 10.1634/theoncologist.2014-0195
- By:
- Publication type:
- Article
Clinical Trial Results. A Pilot Study of Estradiol Followed by Exemestane for Reversing Endocrine Resistance in Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1126, doi. 10.1634/theoncologist.2014-0306
- By:
- Publication type:
- Article
Defining a New Role for the National Cancer Institute Cooperative Groups:More Science, Fewer Trials.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Endocrinology. MicroRNA Expression Profiles in the Management of Papillary Thyroid Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1140, doi. 10.1634/theoncologist.2014-0135
- By:
- Publication type:
- Article
Targeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Assessment of Currently Available Data.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1155, doi. 10.1634/theoncologist.2014-0032
- By:
- Publication type:
- Article
Clinical Trial Results. A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1128, doi. 10.1634/theoncologist.2014-0305
- By:
- Publication type:
- Article
Patient Experience and Attitudes Toward Addressing the Cost of Breast Cancer Care.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1134, doi. 10.1634/theoncologist.2014-0117
- By:
- Publication type:
- Article
Endocrinology. Novel Approaches in Anaplastic Thyroid Cancer Therapy.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1147, doi. 10.1634/theoncologist.2014-0182
- By:
- Publication type:
- Article
Clinical Trial Results. A Phase I/II Study of XELIRI Plus Bevacizumab as Second-Line Chemotherapy for Japanese PatientsWithMetastatic Colorectal Cancer (BIX Study).
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1130, doi. 10.1634/theoncologist.2014-0159
- By:
- Publication type:
- Article
Giant Cell Tumor of Bone.
- Published in:
- 2014
- By:
- Publication type:
- Image
Expanding Public-Private Collaborations to Enhance Cancer Drug Development:A Report of the Institute of Medicine’s Workshop Series, “Implementing a National Cancer Clinical Trials System for the 21st Century”.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1178, doi. 10.1634/theoncologist.2014-0240
- By:
- Publication type:
- Article